The microbiota-gut-brain axis is a crucial link to peripheral and central nervous systems, with
gut health implicated in health and disease, including Alzheimer’s disease (AD) and stress. The
objective of this dissertation is to explore the role of strengthening the gut microbiota in brain
health and early-AD pathologies.
First, I will investigate the effects of probiotic supplementation on cognitive function, brain
inflammation, and gut microbiota composition. We employed a locus coeruleus
hyperphosphorylated pretangle tau rat model, which closely resembles preclinical AD. Rats with
pseudophosphorylated human tau in the LC showed deficits in spatial and olfactory learning,
increased microglia and astrocyte activity, blood-brain barrier (BBB) leakage, and elevated
peripheral inflammation. Probiotic supplementation increased gut microbiome diversity,
optimized bacterial composition, and ameliorated cognitive deficits. A reduction in inflammation
and glycogen synthase kinase 3 beta (GSK-3β) activity in the hippocampus of female rats was
observed, suggesting gut health modulation as a potential therapeutic strategy in preclinical AD,
and providing a possible mechanism underlying AD sex differences.
Second, I examined the effects of probiotics prior to chronic stress or enrichment on cognitive
function and brain health. Probiotics prevented stress-induced spatial memory impairments and
enhanced learning under enrichment conditions. We propose this is linked to increased gut
microbiome diversity and eubiosis, which was observed in our animals. Probiotics prevented
increased levels of the microglia marker ionized calcium-binding adaptor molecule 1 (Iba-1)
found in stressed rats and showed differences in BBB integrity and tyrosine hydroxylase (TH)
levels in the hippocampus between stress and enrichment groups, with beneficial effects
observed in enriched animals.
These findings highlight the potential of probiotics to enhance cognitive function and brain
health through modulation of the gut microbiota, offering a non-invasive therapeutic approach
for AD and stress-related cognitive decline
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.